NCT05092048Unknown不适用
Validation Value of the Questionnaire to Assess Health-related Quality of Life in Patients With CML
xuna1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2021年9月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- Assess health-related Quality of Life and Symptom Burden in patients with chronic myeloid leukemia
研究概览
简要总结
Successful outcomes in CML require both prolonged adherence to oral TKI therapy by patients and careful monitoring of treatment responses by their physicians. Patient Reported Outcomes(PRO) assessment is important to facilitate decisions in the current treatment landscape of CML.
详细描述
- Above 18 years of age.
- Patient with confirmed diagnosis of Philadelphia chromosome positive and/or BCR-ABL positive chronic myeloid leukemia (CML).
- Written informed consent.
- Patients enrolled in investigational drug-trials or other type of clinical trials are also eligible.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Assess health-related Quality of Life and Symptom Burden in patients with chronic myeloid leukemia
时间窗: 1 year
Health-related quality of life (HRQOL) assessment in the current treatment landscape of chronic myeloid leukemia
次要结局
未报告次要终点
研究者
xuna
professor
Nanfang Hospital, Southern Medical University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With DasatinibMyeloid Leukemia, Chronic, Chronic-PhaseNCT02348957Onco Medical Consult GmbH223
招募中
不适用
An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.Eosinophilic EsophagitisNCT05730933Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)72
已完成
4 期
Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND OptimisationChronic Myelogenous Leukemia (CML)NCT01243489Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH104
Unknown
2 期
Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI TreatmentCML, RelapsedNCT03573596Amsterdam UMC, location VUmc134
已完成
不适用
ADHEPTA Study: Adherence Questionnaire in Hepatitis CHepatitis C, ChronicHIV InfectionNCT00998621Fundacion IMIM1,120